Preclinical Remodeling of Human Prostate Cancer through the PTEN/AKT Pathway
Knowledge gained from the identification of genetic and epigenetic alterations that contribute to the progression of prostate cancer in humans is now being implemented in the development of functionally relevant translational models. GEM (genetically modified mouse) models are being developed to inc...
Saved in:
| Main Authors: | Marco A. De Velasco, Hirotsugu Uemura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Advances in Urology |
| Online Access: | http://dx.doi.org/10.1155/2012/419348 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanisms of Immune Evasion in PTEN Loss Prostate Cancer
by: Jorge Esteban-Villarrubia, et al.
Published: (2024-11-01) -
GGCT participates in the malignant process of hepatocellular cancer cells by regulating the PTEN/PI3K/AKT pathway through binding to EZH2
by: Junbo He, et al.
Published: (2025-02-01) -
microRNA-875-5p-conjugated gold nanoparticles suppress breast cancer progression through the MTDH/PTEN/AKT signaling pathway
by: Bin Xiong, et al.
Published: (2024-12-01) -
Xuesaitong Protects Podocytes from Apoptosis in Diabetic Rats through Modulating PTEN-PDK1-Akt-mTOR Pathway
by: Rui Xue, et al.
Published: (2020-01-01) -
Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer.
by: Carmela De Marco, et al.
Published: (2017-01-01)